Clinical trial
Telithromycin in Respiratory Tract Infections
NCT00261105 · Sanofi, Industry · Completed
Key facts
| NCT number | NCT00261105 |
|---|---|
| Title | Telithromycin in Respiratory Tract Infections |
| Official title | An Open, Multicenter, Non-comparative, Phase IV Trial of Efficacy and Safety of Ketek(Telithromycin) 800mg |
| Lead sponsor | Sanofi, Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Respiratory Tract Infections |
| Intervention type | Drug |
| Interventions | telithromycin |
| Start date | Feb 1, 2005 |
| Primary completion | Oct 1, 2005 |
| Completion | Dec 1, 2005 |
| First posted | Dec 2, 2005 |
| Last update posted | Sep 25, 2009 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: